Search Results - Wong, C.K.
- Showing 1 - 3 results of 3
-
1
-
2
-
3
Afatinib versus gefitinib or erlotinib in first-line setting for Malaysia patients with EGFR mutant advanced lung adenocarcinoma by Chai, Chee Shee, Liam, Chong Kin, Lin, O. Po, Pang, Yong Kek, Ho, G. F., Alip, A., Wong, C. K., Poh, M. E.
Published 2019Get full text
Get full text
Get full text
Article
